Your second week on Wegovy: what's normal, what's not, and what changes

Week two remains part of the 0.25 mg tolerability phase (appetite changes are real but often subtle at this stage
Nausea, loose stools and mild fatigue are the most commonly reported side effects in the first two weeks; for most people they ease as the body adjusts
Scale movement in week two is typically small) early loss often reflects fluid shifts rather than fat, so trends over weeks matter more than day-to-day numbers
The starter dose is designed to prepare your system, not to deliver full appetite suppression; that builds with each dose step over the following months

By the second week of Wegovy, most people are still on the 0.25 mg starting dose and still adjusting. Nausea may be present, scale movement is usually modest, and appetite suppression varies day to day. That's entirely normal. The biggest misconception about week two is that you should be feeling dramatic effects already. You won't — and expecting them sets you up for unnecessary frustration. Wegovy is a prescription-only medicine, so how you experience these early weeks should always be discussed with your prescriber.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Week two on Wegovy, examined honestly: symptoms, hunger, and the scale

The myth that week two should feel transformative — and what's actually happening

Many people arrive at week two having read about significant appetite suppression and expect their hunger to have all but disappeared. In reality, 0.25 mg is a tolerability dose. Novo Nordisk designed it that way deliberately: the goal of the first four weeks is to reduce the intensity of gastrointestinal side effects as your system gets used to semaglutide, not to deliver peak pharmacological effect. Full appetite suppression accumulates across months of titration, not days.

The NHS medicines page for semaglutide is clear that treatment takes time to work and that side effects are most noticeable at the start. That framing matters. If week two feels underwhelming compared to what you read online, your treatment is probably progressing exactly as it should.

For a closer look at the specific changes and sensations you can reasonably anticipate as the second week unfolds, our guide to what to expect in week 2 of Wegovy walks through the detail day by day. What you might notice instead: a slight reduction in the urge to snack between meals, food feeling a little heavier than usual, and your appetite returning faster than expected at some meals but not others. These are real, early signals. They are not the full effect. Keep going.

Side effects most people actually report in week two

Nausea is the most talked-about side effect, and it is genuinely common in weeks one and two. It tends to peak in the first day or two after an injection, then ease off before the next dose. Loose stools, constipation, indigestion and burping also appear in this window. Most people find these settle considerably by weeks three and four, particularly if they eat smaller portions, avoid high-fat meals, and stay well hydrated.

Fatigue and mild headaches are also reported in week two, though less discussed. These usually reflect the body adapting to reduced food intake and the medicine's effect on gastric emptying. For practical detail on early side effects and what they indicate, the first-week Wegovy experience guide covers the full picture of how days one to seven typically unfold, which provides useful context for judging what's changed.

One thing worth understanding: side effects in week two do not predict how you'll tolerate the medicine long-term. Some people feel rough for a fortnight and then find higher doses entirely manageable. If symptoms are severe or you're unable to keep fluids down, contact your prescriber rather than waiting.

What the scale is doing, and why it's misleading right now

Some people see a drop of two to four pounds in week two. Others see nothing, or a fluctuation. Neither outcome tells you much about what the next three months hold. Early weight change on GLP-1 medicines frequently reflects water and glycogen shifts rather than fat loss, because reduced carbohydrate intake (a natural consequence of eating less) prompts the body to release stored glycogen, each gram of which carries roughly three grams of water.

The full timeline for how long Wegovy takes to work explains this in detail: meaningful and sustained weight reduction typically becomes visible after the first dose increase, and the trial results that inform NICE's recommendation (published in the STEP 1 trial in the New England Journal of Medicine) were measured over 68 weeks, not 68 days.

The practical advice is to weigh weekly at the same time of day rather than daily, and to track trend lines rather than individual readings. Week two is not the test. It is the prologue.

Practical habits that make week two easier

Protein and hydration are the two levers most within your control right now. Prioritising protein at each meal reduces muscle loss during calorie restriction and tends to improve satiety, even on a modest dose. Aiming for adequate fluid intake matters doubly if you're experiencing loose stools or nausea-driven reduced appetite.

Injection timing is worth settling into a consistent routine now, the same day each week, the same time of day. Some people find morning injections suit them; others prefer evenings. The pen itself is straightforward: pre-filled, single-use, and requires refrigeration. If you started through a regulated pharmacy service, tracking your delivery via DPD and noting the plain, unbranded packaging it arrived in is a reassuring reminder that your supply chain is verified. Store the pen in the fridge door and take it out 30 minutes before injecting to reduce injection-site discomfort.

For a broader picture of what the coming weeks hold, the week-five guide is a useful forward reference, because week five is typically when many people experience the first real appetite shift after the dose steps up. If you're considering the cost of ongoing treatment, the Wegovy pricing page sets out what a transparent, all-inclusive private prescription actually covers. And if you want to read the full overview of how Wegovy works before your next dose, the general Wegovy expectations guide covers the complete arc from first injection through to maintenance.

If you haven't yet started and are trying to understand what you'd be signing up for, checking your eligibility takes a few minutes and is reviewed the same day by a real prescriber.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions